• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在慢性淋巴细胞白血病和淋巴瘤B细胞中,尽管缺乏或酪氨酸激酶激活效率低下,ZAP-70仍能增强B细胞受体信号传导。

ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.

作者信息

Gobessi Stefania, Laurenti Luca, Longo Pablo G, Sica Simona, Leone Giuseppe, Efremov Dimitar G

机构信息

International Centre for Genetic Engineering and Biotechnology (ICGEB) Outstation-Monterotondo, Consiglio Nazionale delle Ricerche (CNR) Campus Adriano Buzzati-Traverso, Rome, Italy.

出版信息

Blood. 2007 Mar 1;109(5):2032-9. doi: 10.1182/blood-2006-03-011759. Epub 2006 Oct 12.

DOI:10.1182/blood-2006-03-011759
PMID:17038529
Abstract

Expression of ZAP-70 is an important negative prognostic factor in chronic lymphocytic leukemia (CLL). This protein tyrosine kinase is a key mediator of T-cell receptor (TCR) signaling and is structurally homologous to Syk, which plays an analogous role in B-cell receptor (BCR) signaling. Recent studies indicate that ZAP-70 may participate in BCR signaling as well, but the mechanism of action is not completely understood. We have now compared antigen receptor-induced activation of ZAP-70 in B cells and T cells by analyzing phosphorylation of critical regulatory tyrosine residues. We show that BCR-mediated activation of ZAP-70 is very inefficient in CLL and lymphoma B cells and is negligible when compared to activation of Syk. Despite the inefficient catalytic activation, the ability of ZAP-70 to recruit downstream signaling molecules in response to antigen receptor stimulation appeared relatively preserved. Moreover, ectopic expression of ZAP-70 enhanced and prolonged activation of several key mediators of BCR signaling, such as the Syk, ERK, and Akt kinases, and decreased the rate of ligand-mediated BCR internalization. We conclude that the role of ZAP-70 in BCR signaling is quite distinct from its role in TCR signaling and is likely mediated by inhibition of events that terminate the signaling response.

摘要

ZAP-70的表达是慢性淋巴细胞白血病(CLL)中一个重要的不良预后因素。这种蛋白酪氨酸激酶是T细胞受体(TCR)信号传导的关键介质,在结构上与Syk同源,Syk在B细胞受体(BCR)信号传导中发挥类似作用。最近的研究表明,ZAP-70也可能参与BCR信号传导,但其作用机制尚未完全明确。我们现在通过分析关键调节酪氨酸残基的磷酸化,比较了抗原受体诱导的B细胞和T细胞中ZAP-70的激活情况。我们发现,BCR介导的ZAP-70激活在CLL和淋巴瘤B细胞中效率非常低,与Syk的激活相比可忽略不计。尽管催化激活效率低下,但ZAP-70响应抗原受体刺激招募下游信号分子的能力似乎相对保留。此外,ZAP-70的异位表达增强并延长了BCR信号传导的几种关键介质(如Syk、ERK和Akt激酶)的激活,并降低了配体介导的BCR内化速率。我们得出结论,ZAP-70在BCR信号传导中的作用与其在TCR信号传导中的作用截然不同,可能是通过抑制终止信号反应的事件来介导的。

相似文献

1
ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.在慢性淋巴细胞白血病和淋巴瘤B细胞中,尽管缺乏或酪氨酸激酶激活效率低下,ZAP-70仍能增强B细胞受体信号传导。
Blood. 2007 Mar 1;109(5):2032-9. doi: 10.1182/blood-2006-03-011759. Epub 2006 Oct 12.
2
Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc.Lck、Syk和ZAP-70酪氨酸激酶在T细胞受体介导的衔接蛋白Shc磷酸化中的作用。
Eur J Immunol. 1998 Aug;28(8):2265-75. doi: 10.1002/(SICI)1521-4141(199808)28:08<2265::AID-IMMU2265>3.0.CO;2-P.
3
Interdomain B in ZAP-70 regulates but is not required for ZAP-70 signaling function in lymphocytes.ZAP-70中的结构域B对淋巴细胞中ZAP-70的信号传导功能具有调节作用,但并非其信号传导功能所必需。
Mol Cell Biol. 1999 Jan;19(1):948-56. doi: 10.1128/MCB.19.1.948.
4
Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.慢性淋巴细胞白血病B细胞中抗原受体结合激活的信号通路。
Autoimmun Rev. 2007 Dec;7(2):102-8. doi: 10.1016/j.autrev.2007.02.021. Epub 2007 Mar 28.
5
Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.吉非替尼靶向表达ZAP-70的慢性淋巴细胞白血病细胞并抑制B细胞受体信号传导。
Cell Death Dis. 2014 Oct 2;5(10):e1439. doi: 10.1038/cddis.2014.391.
6
Mechanisms determining a differential threshold for sensing Src family kinase activity by B and T cell antigen receptors.决定 B 和 T 细胞抗原受体感知Src 家族激酶活性的差异阈值的机制。
J Biol Chem. 2020 Sep 11;295(37):12935-12945. doi: 10.1074/jbc.RA120.013552. Epub 2020 Jul 14.
7
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.ZAP-70的表达与慢性淋巴细胞白血病中B细胞受体信号传导增加有关。
Blood. 2002 Dec 15;100(13):4609-14. doi: 10.1182/blood-2002-06-1683. Epub 2002 Aug 8.
8
Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.人类B淋巴瘤细胞表面的爱泼斯坦-巴尔病毒/C3d受体(gp140、CR2、CD21)的激活会触发Cbl酪氨酸磷酸化,其与p85亚基、Crk-L和Syk的结合以及与Vav的解离。
Cell Signal. 2006 Aug;18(8):1219-25. doi: 10.1016/j.cellsig.2005.10.001. Epub 2005 Nov 14.
9
Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.脾酪氨酸激酶在慢性淋巴细胞白血病发病机制中的作用
Leuk Lymphoma. 2014 Dec;55(12):2699-705. doi: 10.3109/10428194.2014.891026. Epub 2014 Mar 18.
10
A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells.衔接蛋白Cbl-b与激酶zap-70之间的直接相互作用在T细胞中诱导产生阳性信号。
Curr Biol. 1999 Feb 25;9(4):203-6. doi: 10.1016/s0960-9822(99)80090-6.

引用本文的文献

1
B cell development: transcriptional regulation and immunological mechanisms in homeostasis.B细胞发育:稳态中的转录调控与免疫机制
Front Immunol. 2025 Aug 8;16:1593338. doi: 10.3389/fimmu.2025.1593338. eCollection 2025.
2
Calcineurin is an adaptor required for assembly of the TCR signaling complex.钙调磷酸酶是组装 TCR 信号复合物所必需的衔接蛋白。
Cell Rep. 2024 Aug 27;43(8):114568. doi: 10.1016/j.celrep.2024.114568. Epub 2024 Jul 31.
3
Inflammation as a driver of hematological malignancies.炎症作为血液系统恶性肿瘤的驱动因素。
Front Oncol. 2024 Mar 20;14:1347402. doi: 10.3389/fonc.2024.1347402. eCollection 2024.
4
B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia.慢性淋巴细胞白血病发病机制中的B细胞受体信号传导及相关通路
Front Oncol. 2024 Feb 26;14:1339620. doi: 10.3389/fonc.2024.1339620. eCollection 2024.
5
ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia.ZAP-70 增强IGHV 未突变慢性淋巴细胞白血病中的基础 B 细胞受体和 CCR7 信号传导。
Blood Adv. 2024 Mar 12;8(5):1167-1178. doi: 10.1182/bloodadvances.2022009557.
6
A Story of Kinases and Adaptors: The Role of Lck, ZAP-70 and LAT in Switch Panel Governing T-Cell Development and Activation.激酶与接头蛋白的故事:Lck、ZAP-70和LAT在调控T细胞发育与激活的开关面板中的作用
Biology (Basel). 2023 Aug 24;12(9):1163. doi: 10.3390/biology12091163.
7
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications.没食子酸表没食子儿茶素酯在癌症治疗中的潜力:作用机制与临床意义。
Molecules. 2023 Jul 6;28(13):5246. doi: 10.3390/molecules28135246.
8
A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.糖基转移酶 UGT2B17 在 B 细胞受体信号转导中的非经典作用
Cells. 2023 May 2;12(9):1295. doi: 10.3390/cells12091295.
9
Emerging Therapies in CLL in the Era of Precision Medicine.精准医学时代慢性淋巴细胞白血病的新兴疗法
Cancers (Basel). 2023 Mar 3;15(5):1583. doi: 10.3390/cancers15051583.
10
Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry.流式细胞术揭示慢性淋巴细胞白血病患者伊布替尼耐药的表型外观。
Pathol Oncol Res. 2022 Sep 21;28:1610659. doi: 10.3389/pore.2022.1610659. eCollection 2022.